Back to Search Start Over

Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma

Authors :
Alfred S. L. Cheng
Weiqin Yang
Qiaoyi Liang
Jun Yu
Ka Fai To
Wei Kang
Yujuan Dong
Li Zhang
Jesse Chung Sean Pang
Junhong Zhao
Yi Pan
Raymond W.M. Lung
Joanna H.M. Tong
Source :
Molecular Cancer
Publication Year :
2015
Publisher :
Springer Science and Business Media LLC, 2015.

Abstract

Background MicroRNAs (miRNAs) have been reported to play an important role in tumorigenesis. In this study, the role of miR-15a and miR-16-1 in gastric adenocarcinoma (GAC) was investigated. Methods The expression of miR-15a and miR-16-1 in cell lines and primary tumors was examined by miRNA qRT-PCR. Proliferative assays, colony formation, cell invasion and migration, flow cytometry analysis and in vivo study were performed by ectopic expression of miR-15a and miR-16-1. The putative target genes of miR-15a and miR-16-1 were explored by TargetScan and further validated. Results We found that miR-15a and miR-16-1 were down-regulated in GAC cell lines and primary tumor samples compared with normal gastric epithelium. Functional study demonstrated that ectopic expression of miR-15a and miR-16-1 suppressed cell proliferation, monolayer colony formation, invasion and migration, and xenograft formation in vivo. In addition, miR-15a and miR-16-1 induced G0/G1 cell cycle arrest which was further confirmed by Western blot and qRT-PCR of related cell cycle regulators. YAP1 was confirmed to be a functional target of miR-15a and miR-16-1 in GAC. YAP1 re-expression partly abrogated the inhibitory effect of miR-15a and miR-16-1 in GAC cells. In clinical samples, YAP1 protein expression shows negative correlation with miR-15a and miR-16-1 expression. Conclusion In conclusion, targeting YAP1 by tumor suppressor miRNA miR-15a and miR-16-1 plays inhibitory effect and this might have a therapeutic potential in GAC. Electronic supplementary material The online version of this article (doi:10.1186/s12943-015-0323-3) contains supplementary material, which is available to authorized users.

Details

ISSN :
14764598
Volume :
14
Database :
OpenAIRE
Journal :
Molecular Cancer
Accession number :
edsair.doi.dedup.....cd18f44920b114f11779e9a19d26a3b9
Full Text :
https://doi.org/10.1186/s12943-015-0323-3